Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
12-May-2026 | 552.5 | 554.2 | 515 | 548.1 | 35,950 | 42,38,52,416.4 | 3,19,892 |
13-May-2026 | 549 | 559.1 | 541.3 | 548 | 14,756 | 16,58,25,460.35 | 1,40,720 |
14-May-2026 | 600 | 600 | 532 | 540.7 | 86,583 | 1,60,33,15,889.25 | 5,11,779 |
15-May-2026 | 534.9 | 549.05 | 522.5 | 528.85 | 15,547 | 21,02,30,581.2 | 1,83,516 |
18-May-2026 | 522.5 | 523 | 505 | 507.4 | 18,395 | 14,51,79,791.85 | 1,20,579 |
19-May-2026 | 506.9 | 513.2 | 504.2 | 508.4 | 12,328 | 8,90,38,012.5 | 83,824 |
20-May-2026 | 507.4 | 520.45 | 495.7 | 518.3 | 18,725 | 15,33,25,397.95 | 1,55,726 |
21-May-2026 | 525.05 | 537.35 | 525.05 | 528.8 | 15,507 | 23,15,09,449.05 | 2,93,962 |
22-May-2026 | 528 | 528.1 | 515.05 | 518.95 | 12,382 | 7,23,51,151 | 70,579 |
25-May-2026 | 527 | 527 | 513.15 | 524.5 | 9,724 | 6,41,17,785.2 | 63,182 |
26-May-2026 | 526.5 | 544 | 524.7 | 540.85 | 11,022 | 25,68,92,880.75 | 3,50,362 |
27-May-2026 | 543.6 | 549.1 | 534 | 536.15 | 7,988 | 7,57,54,444.3 | 78,460 |
29-May-2026 | 531 | 565 | 531 | 555.35 | 18,416 | 25,39,68,881.15 | 3,06,674 |
01-Jun-2026 | 560 | 560 | 535.05 | 540.85 | 9,205 | 8,14,04,693.4 | 70,522 |
02-Jun-2026 | 540.85 | 549.95 | 528.9 | 541.5 | 14,736 | 10,31,05,081.8 | 1,02,753 |
03-Jun-2026 | 538 | 541.7 | 527.05 | 536.15 | 4,821 | 3,85,18,893.05 | 38,062 |
04-Jun-2026 | 530.1 | 551 | 530.1 | 544.15 | 18,676 | 11,61,41,425.1 | 99,018 |
05-Jun-2026 | 544.15 | 554.2 | 530.4 | 533.2 | 9,745 | 8,88,27,619.4 | 84,904 |
08-Jun-2026 | 520 | 538.8 | 520 | 529.65 | 8,417 | 4,32,26,897.6 | 38,047 |
09-Jun-2026 | 537.05 | 539 | 529.4 | 535.55 | 4,394 | 2,89,91,843.2 | 29,528 |
10-Jun-2026 | 538.7 | 539.65 | 522.05 | 524.45 | 6,846 | 3,35,55,980.8 | 37,533 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
